Abstract
Cooperative innovation is an important means to promote the development of medical and health undertakings. Based on the award data of the Chinese Medical Science and Technology Award from 2003 to 2022, this paper constructs an innovation cooperation network and uses social network analysis to explore the structure and evolution characteristics of China’s medical and health innovation cooperation network. The research shows that China’s medical and health innovation cooperation continues to increase, but the development of regional cooperation is not balanced; the scale of the network is expanding, and the small world effect is obvious, but the network density is relatively low, and there is still a large space for development of institutional innovation cooperation; Hospitals and universities play an important role in the network; The medical and health innovation cooperation network has the characteristics of community. Finally, policy suggestions are put forward from the aspects of strengthening regional balanced development, giving play to the radiation role of core institutions in the innovation cooperative network, and promoting diversified innovation cooperation, to form a balanced development innovation cooperation system, a robust innovation cooperation network ecology, and a stable innovation cooperation network structure.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
E-mail: yzcyhzsf{at}163.com
Data Availability
The data underlying the results presented in the study are available from Chinese Medical Association (https://www.cma.org.cn/col/col38/index.html ).
